Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 175,559 shares at $9.06 ($1.6M) on 2023-12-06, disclosed to the SEC on 2023-12-08.
Open-market purchase of $1.6M PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.95 | 9,933 | $59K | 3.8% |
| 2 | $9.06 | 82,813 | $750K | 48.1% |
| 3 | $9.06 | 82,813 | $750K | 48.1% |
| Total | $8.88 avg | 175,559 | $1.6M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |